Cell Therapeutics drug draws US FDA staff concerns – Reuters
TheStreet.com
Cell Therapeutics drug draws US FDA staff concernsReutersWASHINGTON, Feb 8 (Reuters) – US drug reviewers questioned effectiveness data from Cell Therapeutics Inc (CTIC.O) (CTIC.MI) for an experimental lymphoma drug and said the medicine had substantial side effects, according to documents …Abridged Study to Haunt CTI? FDA Questions Pixantrone DataBioWorld OnlineFDA Tough on Cell Therapeutics' DrugTheStreet.comUPDATE [...]










